Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.

Al-Husseini A, Wazaify M, Van Hout MC.

Int J Ment Health Addict. 2018;16(3):642-654. doi: 10.1007/s11469-017-9813-4. Epub 2017 Sep 15.

2.

Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies.

Al-Husseini A, Abu-Farha R, Wazaify M, Van Hout MC.

Saudi Pharm J. 2018 Mar;26(3):306-310. doi: 10.1016/j.jsps.2018.01.012. Epub 2018 Jan 31.

3.

Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.

Al-Husseini A, Kraskauskas D, Mezzaroma E, Nordio A, Farkas D, Drake JI, Abbate A, Felty Q, Voelkel NF.

Pulm Circ. 2015 Mar;5(1):101-16. doi: 10.1086/679704.

4.

Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension.

Al-Husseini A, Wijesinghe DS, Farkas L, Kraskauskas D, Drake JI, Van Tassel B, Abbate A, Chalfant CE, Voelkel NF.

PLoS One. 2015 Mar 18;10(3):e0120157. doi: 10.1371/journal.pone.0120157. eCollection 2015.

5.

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.

Nicolls MR, Mizuno S, Taraseviciene-Stewart L, Farkas L, Drake JI, Al Husseini A, Gomez-Arroyo JG, Voelkel NF, Bogaard HJ.

Pulm Circ. 2012 Oct;2(4):434-42. doi: 10.4103/2045-8932.105031.

6.

Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?

Voelkel NF, Bogaard HJ, Al Husseini A, Farkas L, Gomez-Arroyo J, Natarajan R.

Antioxid Redox Signal. 2013 May 10;18(14):1810-7. doi: 10.1089/ars.2012.4828. Epub 2012 Sep 28. Review.

PMID:
22870869
7.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Mizuno S, Farkas L, Al Husseini A, Farkas D, Gomez-Arroyo J, Kraskauskas D, Nicolls MR, Cool CD, Bogaard HJ, Voelkel NF.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):679-87. doi: 10.1165/rcmb.2012-0077OC. Epub 2012 Jul 27.

8.

Severe pulmonary hypertension: The role of metabolic and endocrine disorders.

Bogaard HJ, Al Husseini A, Farkas L, Farkas D, Gomez-Arroyo J, Abbate A, Voelkel NF.

Pulm Circ. 2012 Apr-Jun;2(2):148-54. doi: 10.4103/2045-8932.97592.

9.

Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.

Al Husseini A, Bagnato G, Farkas L, Gomez-Arroyo J, Farkas D, Mizuno S, Kraskauskas D, Abbate A, Van Tassel B, Voelkel NF, Bogaard HJ.

Eur Respir J. 2013 Jan;41(1):104-14. doi: 10.1183/09031936.00196511. Epub 2012 Jul 26.

Supplemental Content

Loading ...
Support Center